These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 36246181

  • 1. Phase 1 Clinical Trial of Elamipretide in Dry Age-Related Macular Degeneration and Noncentral Geographic Atrophy: ReCLAIM NCGA Study.
    Mettu PS, Allingham MJ, Cousins SW.
    Ophthalmol Sci; 2022 Mar; 2(1):100086. PubMed ID: 36246181
    [Abstract] [Full Text] [Related]

  • 2. Phase 1 Clinical Trial of Elamipretide in Intermediate Age-Related Macular Degeneration and High-Risk Drusen: ReCLAIM High-Risk Drusen Study.
    Allingham MJ, Mettu PS, Cousins SW.
    Ophthalmol Sci; 2022 Mar; 2(1):100095. PubMed ID: 36246187
    [Abstract] [Full Text] [Related]

  • 3. A Phase I, Single Ascending Dose Study of GEM103 (Recombinant Human Complement Factor H) in Patients with Geographic Atrophy.
    Khanani AM, Maturi RK, Bagheri N, Bakall B, Boyer DS, Couvillion SS, Dhoot DS, Holekamp NM, Jamal KN, Marcus DM, Pieramici D, Aziz AA, Patki KC, Bridges WZ, Barone SB.
    Ophthalmol Sci; 2022 Jun; 2(2):100154. PubMed ID: 36249705
    [Abstract] [Full Text] [Related]

  • 4. Safety and Efficacy of Subretinally Administered Palucorcel for Geographic Atrophy of Age-Related Macular Degeneration: Phase 2b Study.
    Heier JS, Ho AC, Samuel MA, Chang T, Riemann CD, Kitchens JW, Slakter JS, Leiderman YI, Spencer R, Williams GA, Hickson-Curran SB, Keane M, Baldassarre JS, Prelude Study Group.
    Ophthalmol Retina; 2020 Apr; 4(4):384-393. PubMed ID: 32033908
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Subthreshold Nanosecond Laser Intervention in Intermediate Age-Related Macular Degeneration: Study Design and Baseline Characteristics of the Laser in Early Stages of Age-Related Macular Degeneration Study (Report Number 1).
    Lek JJ, Brassington KH, Luu CD, Chen FK, Arnold JJ, Heriot WJ, Durkin SR, Chakravarthy U, Guymer RH, Laser in Early Stages of Age-Related Macular Degeneration Study Writing Committee.
    Ophthalmol Retina; 2017 Apr; 1(3):227-239. PubMed ID: 31047426
    [Abstract] [Full Text] [Related]

  • 9. Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results from the Prospective Proxima A and B Clinical Trials.
    Holekamp N, Wykoff CC, Schmitz-Valckenberg S, Monés J, Souied EH, Lin H, Rabena MD, Cantrell RA, Henry EC, Tang F, Swaminathan B, Martin J, Ferrara D, Staurenghi G.
    Ophthalmology; 2020 Jun; 127(6):769-783. PubMed ID: 32081489
    [Abstract] [Full Text] [Related]

  • 10. Association of Low Luminance Questionnaire With Objective Functional Measures in Early and Intermediate Age-Related Macular Degeneration.
    Thompson AC, Luhmann UFO, Stinnett SS, Vajzovic L, Horne A, Toth CA, Cousins SW, Lad EM.
    Invest Ophthalmol Vis Sci; 2018 Jan 01; 59(1):289-297. PubMed ID: 29340643
    [Abstract] [Full Text] [Related]

  • 11. Impact of Cataract Surgery on Low Luminance Visual Acuity Deficit Measurements.
    Shen M, Shi Y, Wang L, Russell JF, Jiang X, Laiginhas R, Iyer P, Trivizki O, Thulliez M, Yoo SH, Rose TP, Habash RG, Amescua G, Feuer WJ, Gregori G, Rosenfeld PJ.
    Ophthalmol Sci; 2022 Sep 01; 2(3):100170. PubMed ID: 36245760
    [Abstract] [Full Text] [Related]

  • 12. Elamipretide Topical Ophthalmic Solution for the Treatment of Subjects with Leber Hereditary Optic Neuropathy: A Randomized Trial.
    Karanjia R, Sadun AA.
    Ophthalmology; 2024 Apr 01; 131(4):422-433. PubMed ID: 37923251
    [Abstract] [Full Text] [Related]

  • 13. Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.
    Liao DS, Grossi FV, El Mehdi D, Gerber MR, Brown DM, Heier JS, Wykoff CC, Singerman LJ, Abraham P, Grassmann F, Nuernberg P, Weber BHF, Deschatelets P, Kim RY, Chung CY, Ribeiro RM, Hamdani M, Rosenfeld PJ, Boyer DS, Slakter JS, Francois CG.
    Ophthalmology; 2020 Feb 01; 127(2):186-195. PubMed ID: 31474439
    [Abstract] [Full Text] [Related]

  • 14. C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial.
    Jaffe GJ, Westby K, Csaky KG, Monés J, Pearlman JA, Patel SS, Joondeph BC, Randolph J, Masonson H, Rezaei KA.
    Ophthalmology; 2021 Apr 01; 128(4):576-586. PubMed ID: 32882310
    [Abstract] [Full Text] [Related]

  • 15. Longitudinal Evaluation of Visual Function Impairments in Early and Intermediate Age-Related Macular Degeneration Patients.
    Lad EM, Fang V, Tessier M, Rautanen A, Gayan J, Stinnett SS, Luhmann UFO.
    Ophthalmol Sci; 2022 Sep 01; 2(3):100173. PubMed ID: 36245764
    [Abstract] [Full Text] [Related]

  • 16. Quantification of Geographic Atrophy Using Spectral Domain OCT in Age-Related Macular Degeneration.
    Cleland SC, Konda SM, Danis RP, Huang Y, Myers DJ, Blodi BA, Domalpally A.
    Ophthalmol Retina; 2021 Jan 01; 5(1):41-48. PubMed ID: 32679202
    [Abstract] [Full Text] [Related]

  • 17. Microperimetric correlations of autofluorescence and optical coherence tomography imaging in dry age-related macular degeneration.
    Querques L, Querques G, Forte R, Souied EH.
    Am J Ophthalmol; 2012 Jun 01; 153(6):1110-5. PubMed ID: 22321805
    [Abstract] [Full Text] [Related]

  • 18. Visual Function Decline Resulting from Geographic Atrophy: Results from the Chroma and Spectri Phase 3 Trials.
    Heier JS, Pieramici D, Chakravarthy U, Patel SS, Gupta S, Lotery A, Lad EM, Silverman D, Henry EC, Anderesi M, Tschosik EA, Gray S, Ferrara D, Guymer R, Chroma and Spectri Study Investigators.
    Ophthalmol Retina; 2020 Jul 01; 4(7):673-688. PubMed ID: 32199866
    [Abstract] [Full Text] [Related]

  • 19. Exploratory Study on Visual Acuity and Patient-Perceived Visual Function in Patients with Subretinal Drusenoid Deposits.
    Grewal MK, Chandra S, Gurudas S, Bird A, Jeffery G, Sivaprasad S.
    J Clin Med; 2020 Sep 01; 9(9):. PubMed ID: 32882940
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.